Oct 27, 2019
In this episode, Cameron Kiani interviews Ken Gillman, MD, on
using Monoamine Oxidase Inhibitors in clinical practice.
Dr. Gillman is a Queensland-based psychiatrist considered to
be one of the world's leading experts on MAOIs. He recently
published a statement “Revitalizing monoamine oxidase inhibitors: a
call for action” in the journal CNS Spectrums.
Cameron Kiani is a fourth year medical student at Icahn School
of Medicine at Mount Sinai with an interest in treatment-resistant
“Revitalizing monoamine oxidase inhibitors: a call for